ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed
Xiangrui Liu
Matched on ORCID iD 0000-0003-4960-5847; OpenAlex author ID A5078387716. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper
Papers 4
- Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. Last author DOI 10.1016/j.biomaterials.2021.121176↗
- New path to treating pancreatic cancer: TRAIL gene delivery targeting the fibroblast-enriched tumor microenvironment. Co-author DOI 10.1016/j.jconrel.2018.07.047↗
- Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast-induced drug resistance. First author DOI 10.1016/j.biomaterials.2017.08.002↗
- GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenvironment. Co-author DOI 10.1038/s41598-017-13869-0↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Youqing Shen · 4 shared papers, 2017–2021 · strength 0.36
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176↗
- Paper GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenviron… DOI 10.1038/s41598-017-13869-0↗
- Paper New path to treating pancreatic cancer: TRAIL gene delivery targeting the fibroblast-enriched tumor microenvironment. DOI 10.1016/j.jconrel.2018.07.047↗
- Quan Zhou · 3 shared papers, 2017–2021 · strength 0.28
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176↗
- Paper GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenviron… DOI 10.1038/s41598-017-13869-0↗
- Paper Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibr… DOI 10.1016/j.biomaterials.2017.08.002↗
- Haiping Jiang · 2 shared papers, 2018–2021 · strength 0.20
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176↗
- Paper New path to treating pancreatic cancer: TRAIL gene delivery targeting the fibroblast-enriched tumor microenvironment. DOI 10.1016/j.jconrel.2018.07.047↗
- Liying Wang · 2 shared papers, 2017–2021 · strength 0.18
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176↗
- Paper Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibr… DOI 10.1016/j.biomaterials.2017.08.002↗
- Xiangsheng Liu · 1 shared paper, 2021 · strength 0.12
- Liping Cao · 1 shared paper, 2021 · strength 0.12
- Huan Meng · 1 shared paper, 2021 · strength 0.12
- Lisong Teng · 1 shared paper, 2018 · strength 0.08
- Zipeng Lu · 1 shared paper, 2017 · strength 0.06
- Yi Miao · 1 shared paper, 2017 · strength 0.06
- Weilin Wang · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.